Home / Peptides / Peptides for Energy

Do Peptides Give You Energy? MOTS-c, Fatigue Work-ups and the Evidence

No peptide is a proven treatment for fatigue: MOTS-c improves insulin sensitivity and exercise capacity in mice and rises with exercise in people, but has no human trial showing more energy, so a work-up for sleep, thyroid, iron and hormones comes first.

M
Written by
B.Sc. (Hons) Chemistry, MBA Pharma Mgmt (Pursuing) · Scientific Content Writer, Strong Health
D
Medically reviewed by
M.D., Staff Psychiatrist · Medical Reviewer, Strong Health
Published: July 23, 2026 Updated: November 3, 2026 · Editorial Standards
8 min read

Key takeaways

  • No peptide is a proven treatment for fatigue; the biggest gains come from fixing sleep, thyroid, iron, B12, hormones and metabolic health.
  • MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA that activates AMPK and, in mice, prevented age- and diet-induced insulin resistance and obesity.[1]
  • MOTS-c is exercise-induced: blood levels rise with exercise in humans, and it regulates age-related physical decline in mice.[2]
  • There is no human trial showing MOTS-c injections improve energy or any clinical outcome.[2][3]
  • Compounding access is product-specific; conditional enforcement discretion does not establish FDA approval or treatment benefit.[90][91]

Does MOTS-c work in humans?

MOTS-c has not been shown to work in humans: the evidence comes from cells and mice, where it prevented age- and diet-induced insulin resistance and obesity, and from observational data showing it rises in people after exercise.[1][2] We’re candid about the gap here. In animal work AMPK activation is the recurring mechanism.[3]

“MOTS-c treatment in mice prevented age-dependent and high-fat-diet-induced insulin resistance, as well as diet-induced obesity.”

Lee C, et al., Cell Metabolism, 2015 — PubMed

Human data are far more limited. Circulating MOTS-c rises with exercise and differs across metabolic states, which supports its biological relevance, but there are no large randomized trials showing that administering MOTS-c produces meaningful energy or clinical benefit in people.[2]

MOTS-c is mechanistically compelling with genuinely thin human efficacy data. It is not a substitute for training, sleep, and nutrition. At most it may support the metabolic adaptations those produce.

Why am I so tired all the time?

Persistent tiredness usually has an identifiable, treatable cause: poor or insufficient sleep, thyroid dysfunction, iron or B12 deficiency, low testosterone, blood-sugar problems, depression or a medication effect. “Low energy” is a symptom, not a diagnosis, and chasing it with a peptide before ruling these out is backwards.

Common causes of fatigue, how they are found, and what fixes them
Cause Typical clue Test What helps
Insufficient or poor-quality sleep Under 7 hours, snoring, unrefreshing sleep Sleep history; sleep study if snoring or apnea is suspected Treat the sleep disorder; see our sleep guide
Hypothyroidism Cold intolerance, weight gain, dry skin TSH, free T4 Levothyroxine
Iron or B12 deficiency Heavy periods, restless legs, numbness Ferritin, complete blood count, B12 Replace the deficiency
Low testosterone Low libido, low mood, loss of muscle Morning total and free testosterone Evaluation; TRT only if confirmed
Depression or burnout Loss of interest, poor concentration PHQ-9 screen, clinical interview Therapy, medication, workload change
MOTS-c None (not a cause; a proposed treatment) No human efficacy trial Mouse data only[1]

So the honest starting point isn’t a compound. It’s a work-up. Only once the fixable causes are addressed does it make sense to ask whether a peptide adds anything.

No peptide is a proven treatment for fatigue. The biggest wins usually come from correcting sleep, hormones, iron, thyroid, and metabolic health, not from an injection.

What is MOTS-c?

MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial genome (within the 12S rRNA gene) that regulates insulin sensitivity and metabolic homeostasis, with skeletal muscle as its main target.[1] Mitochondria are your cells’ power plants, so a signal that comes from them is a natural focus for energy metabolism. For background on cellular energy production, see our guide to NADH and energy metabolism.

MOTS-c’s best-studied action is activating AMP-activated protein kinase (AMPK), the cell’s central energy sensor. Switching on AMPK shifts cells toward taking up glucose and burning fat more efficiently, broadly the same pathway engaged by exercise, which is why MOTS-c is often described as an “exercise-mimetic.”[1][2]

What other peptides come up for energy?

Two adjacent areas come up for energy: sleep peptides, because deep sleep is where the body restores energy, and GH secretagogues, whose effects on energy are indirect:

  • •Sleep peptides, because deep sleep is where the body restores energy, improving sleep quality can do more for daytime energy than any “energy” compound.
  • •GH secretagogues and longevity peptides, discussed for vitality and body composition, though “energy” benefits are indirect and individual.

If low energy is really about body composition or metabolic health, our guides to weight loss and longevity may be more relevant.

How does Strong Health approach low energy?

We start with the work-up. A history and targeted labs, which can include thyroid function, ferritin/iron studies, B12, testosterone, fasting glucose and metabolic markers, mean we’re treating a cause, not a symptom. Fixing an iron deficiency or a sleep disorder beats any peptide.

Compounding access is specific to the substance, route and current federal and state requirements. The October 2026 HHS policy describes conditional enforcement discretion for six specified substances under section 503A; it is not FDA approval or a finding of effectiveness. It does not establish blanket 503B access. Review the exact proposed product with the prescriber and pharmacist.[90][91]

Is MOTS-c safe?

MOTS-c has a limited human safety record. In preclinical work it has generally been well tolerated, and reported effects in clinical use tend to be mild, most often injection-site irritation. Because long-term human safety data don’t yet exist, we screen carefully and monitor throughout a cycle.

Frequently Asked Questions

Do peptides give you more energy?
No peptide is a proven treatment for fatigue. MOTS-c activates AMPK, the cell’s energy sensor, and is studied for metabolism, but human evidence is thin. The biggest energy gains usually come from correcting sleep, hormones, iron, thyroid, and metabolic health first.
What does MOTS-c do?
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA that acts as a metabolic signal. In cells it inhibits the folate cycle and purine synthesis, which activates AMPK, the enzyme that switches cells toward taking up glucose and burning fat. In mice it prevented age-related and diet-induced insulin resistance and obesity and improved physical performance. In people, blood levels rise after exercise. What it does when injected into humans has not been tested in a controlled trial.
Is MOTS-c an exercise mimetic?
Partly, in animals. MOTS-c activates AMPK, the same energy-sensing pathway exercise turns on, and in mice it improved running capacity and metabolic health, which is why researchers call it exercise-induced and exercise-mimetic. In humans it is released into the blood during exercise, but no trial shows that injecting it reproduces the fitness, body-composition or energy benefits of training. Treat the label as a description of mechanism, not a substitute for exercise.
Why am I so tired all the time?
Fatigue has many common, treatable causes: poor sleep, thyroid problems, low iron or B12, low testosterone, blood-sugar issues, depression, and medications among them. The right first step is a medical work-up to find and fix the cause, not a peptide.
Are energy peptides FDA-approved?
Compounding is substance- and route-specific. The October 2026 HHS policy describes conditional enforcement discretion for six specified substances under section 503A. It does not establish FDA approval, effectiveness or blanket 503B access. Your clinician and pharmacist should confirm current federal and state requirements for the exact proposed product.
Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Authorship and review information are shown where recorded; an editorial update is not a new medical review.

Related Articles

Molecules in this guide

Browse the molecule library →

Compare the research, safety questions and regulatory context for each molecule. Inclusion in this guide does not establish effectiveness or treatment availability.

Looking for care? View Strong Health locations and visit options.

Running on Empty?

Our physicians look for the real drivers of fatigue (hormones, metabolism, sleep, and more) before considering whether a peptide adds anything.

References & Citations

  1. Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015.
  2. Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021.
  3. Kim KH, et al. Mitochondrial-derived peptides in aging and age-related diseases. Geroscience. 2021.
  4. FDA. Human Drug Compounding. Accessed November 3, 2026.
  5. HHS. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. October 2026; accessed November 3, 2026.
👉 Book a Free Peptide Therapy Assessment